Selecting pharmaceutical excipients requires a comprehensive evaluation based on three core dimensions: the characteristics of the active pharmaceutical ingredient (API), the objectives of the drug formulation, and regulatory safety requirements. The ultimate goal is to ensure the safety, efficacy, and stability of the medicinal product while maintaining full regulatory compliance. The selection process can be approached as follows:
Define the Core Characteristics of the API
This serves as the foundational step for excipient selection; it is essential to clarify the key attributes of the active ingredient:
Understand the physicochemical properties of the drug, such as its solubility, stability, and hygroscopicity. For poorly soluble drugs, prioritize the use of solubilizers or carriers for solid dispersions; for hygroscopic drugs, select excipients with excellent moisture-barrier properties.
Conduct compatibility studies between the API and potential excipients early on to rule out chemical reactions that could produce harmful impurities. For example, when developing nizatidine formulations, it is necessary to screen for neutral microcrystalline cellulose to prevent the formation of genotoxic nitrosamine impurities above acceptable limits.
Align with Formulation and Route of Administration Requirements
Different dosage forms and routes of administration impose vastly different requirements regarding the functionality and safety thresholds of excipients:
Oral solid dosage forms: Tablets require the inclusion of disintegrants, lubricants, and binders; for capsules, focus on the compatibility between the filler and the capsule shell; for granules, prioritize excipients with good flowability and rapid dissolution properties.
Injectables: Must utilize sterile, pyrogen-free, pharmaceutical-grade excipients. Osmolality and pH levels must be strictly controlled to align with human physiological conditions. Generally, bacteriostatic agents are prohibited in formulations intended for intravenous or intraspinal administration.
Formulations for special populations: For pediatric formulations, avoid excipients such as benzyl alcohol or propylene glycol, which are toxic to newborns. Instead, prioritize the use of flavoring agents that offer low irritation and ensure high patient compliance.
